SCHEMBL7239342

SCHEMBL7239342

NC(=O)c1ccc(CN2CCc3ccc(C(=O)CCCC4CCN(Cc5ccccc5Cl)CC4)cc3CC2)cc1

nearest known ligand 0.59

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ACHE P22303 16/20 0.59
FAAH O00519 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7227807 0.93 ACHE (0.55) ACHEFAAH
Hydrochloric Acid SCHEMBL7236861 0.92 ACHE (0.64) ACHEFAAH
Hydrochloric Acid SCHEMBL7226809 0.91 ACHE (0.58) ACHEFAAH
Hydrochloric Acid SCHEMBL7227943 0.91 ACHE (0.58) ACHEFAAH
Hydrochloric Acid SCHEMBL7227351 0.91 ACHE (0.58) ACHEFAAH
Hydrochloric Acid SCHEMBL7227921 0.90 ACHE (0.66) ACHE
SCHEMBL7227784 0.90 ACHE (0.60) ACHEFAAH
SCHEMBL7228201 0.89 ACHE (0.58) ACHEFAAH
SCHEMBL7226270 0.89 ACHE (0.56) ACHEFAAH
Hydrochloric Acid SCHEMBL7226334 0.89 ACHE (0.59) ACHEFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6534496-B1 Prophylactic and/or therapeutic drug for obesity and obesity associated diseasestor diabetes with a reduced risk for central side effects and high universality in usage. Another object of the a lipolytic agent, or a prophylactic and/or TAKEDA CHEMICAL INDUSTRIES, INC. (JP) 2003-03-18 US disclosed